Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder. The
available therapy is limited to the symptomatic treatment and its efficacy remains …

Quinones can in principle be viewed as a double-edged sword in the treatment of
neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic …

Compartmentalization is a characterizing feature of complexity in cells, used to organize
their biochemistry. Membrane-bound organelles are most widely known, but non-membrane …

Beta-amyloid (Aβ) aggregation has been strongly associated with the neurodegenerative
pathology and a cascade of harmful event rated to Alzheimer's disease (AD). Inhibition of Aβ …

Alzheimer's disease (AD) is a complex, multi-factorial neurodegenerative disease. The
aggregation of soluble β-amyloid (Aβ) into fibrillar deposits is a pathological hallmark of AD …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized
by memory loss, cognitive impairment, and functional decline leading to dementia and …

Protein misfolding and aggregation are associated with more than twenty diseases, such as
neurodegenerative diseases and metabolic diseases. The amyloid oligomers and fibrils may …

Alzheimer's disease is a progressive, neurodegenerative disorder that is the leading cause
of senile dementia, afflicting millions of individuals worldwide. Since the identification of the …

In addition to amyloid cascade hypothesis, ferroptosis–a recently identified cell death
pathway associated with the accumulation of lipid hydroperoxides–was hypothesized as …

Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by the
deposition of amyloids in the brain. One prominent form of amyloid is composed of repeating …